XML 41 R30.htm IDEA: XBRL DOCUMENT

STOCKHOLDERS' EQUITY AND STOCK OPTIONS (Tables)

12 Months Ended

Jan. 31, 2013

Share-Based Arrangements With Employees and Nonemployees [Abstract]

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

The following table represents our stock options granted, exercised and forfeited during the fiscal year ended January 31, 2013.

Stock Options		Number of Shares				Weighted Average Exercise Price per Share				Weighted Average Remaining Contractual Term				Aggregate Intrinsic Value
Outstanding at January 31, 2012			18,200			$	7.31				3.38 years			$	10,230
Granted during the year ended January 31, 2013			10,000			$	6.44				5.39 years			$	100
Forfeited during the year ended January 31, 2013			(4,200	)		$	10.67				—				—
Outstanding at January 31, 2013			24,000			$	7.47				3.95 years			$	1,300
Exercisable at January 31, 2013			24,000			$	7.47				3.95 years			$	1,300
Reserved for future issuance			0
Directors’ Plan (expired on December 31, 2012)

Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]

Restricted Stock Plan 2012 Equity Plan		Shares Authorized Under 2012 Plan as revised				Outstanding Unvested Grants at Maximum at End of FY13				Shares Remaining Available for Future Issuance
Restricted stock grants - employees			173,000				164,500				8,500
Restricted stock grants - directors			50,000				49,500				500
Matching award program			9,000				—				9,000
Bonus in stock - employees			40,000				21,517				18,483
Retainer in stock - directors			38,000				6,601				31,399
Total restricted stock plan			310,000				242,118				67,882

Total Restricted Shares		Outstanding Unvested Grants at Maximum at Beginning of FY13				Granted during FY13				Becoming Vested during FY13				Forfeited during FY13				Outstanding Unvested Grants at Maximum at End of FY13
Restricted stock grants - employees			129,536				164,500				79,313				50,223				164,500
Restricted stock grants - directors			63,184				49,500				45,232				17,952				49,500
Matching award program			3,500				—				—				—				3,500
Bonus in stock - employees			25,801				24,806				3,000				—				47,607
Retainer in stock - directors			5,572				7,717				—				—				13,289
Total restricted stock plan			227,593				246,523				127,545				68,175				278,396

Shares under 2012 Equity Plan		Outstanding Unvested Grants at Maximum at Beginning of FY13				Granted during FY13				Becoming Vested during FY13				Forfeited during FY13				Outstanding unvested grants at maximum at end of FY13
Restricted stock grants – employees			—				164,500				—				—				164,500
Restricted stock grants - directors			—				49,500				—				—				49,500
Matching award program			—				—				—				—				—
Bonus in stock - employees			—				21,517				—				—				21,517
Retainer in stock - directors			—				6,601				—				—				6,601
Total restricted stock plan			—				242,118				—				—				242,118

Shares under 2009 Equity Plan		Outstanding Unvested Grants at Maximum at Beginning of FY13				Granted during FY13				Becoming Vested during FY13				Forfeited during FY13				Outstanding unvested grants at maximum at end of FY13
Restricted stock grants - employees			129,536				—				79,313				50,223				—
Restricted stock grants - directors			63,184				—				45,232				17,952				—
Matching award program			3,500				—				—				—				3,500
Bonus in stock - employees			25,801				3,289				3,000				—				26,090
Retainer in stock - directors			5,572				1,116				—				—				6,688
Total restricted stock plan			227,593				4,405				127,545				68,175				36,278

Overall weighted average per share - all plans		Outstanding Unvested Grants at Maximum at Beginning of FY13				Granted during FY13				Becoming Vested during FY13				Forfeited during FY13				Outstanding unvested grants at maximum at end of FY13
Restricted stock grants – employees		$	8.00			$	6.44			$	8.00			$	8.00			$	6.44
Restricted stock grants - directors			8.00				6.44				8.00				8.00				6.44
Matching award program			8.14				—				—				—				8.14
Bonus in stock - employees			8.50				5.55				9.31				—				6.91
Retainer in stock - directors			8.49				6.65				—				—				7.42
Total restricted stock plan		$	8.07			$	6.36			$	8.03			$	8.00			$	6.59

Shares under 2012 Equity Plan		Outstanding Unvested Grants at Maximum at Beginning of FY13				Granted during FY13				Becoming Vested during FY13				Forfeited during FY13				Outstanding unvested grants at maximum at end of FY13
Restricted stock grants – employees		$	—			$	6.44			$	—			$	—			$	6.44
Restricted stock grants - directors			—				6.44				—				—				6.44
Matching award program			—				—				—				—				—
Bonus in stock - employees			—				5.41				—				—				5.41
Retainer in stock - directors			—				6.01				—				—				6.01
Total restricted stock plan		$	—			$	6.34			$	—			$	—			$	6.34

Shares under 2009 Equity Plan		Outstanding Unvested Grants at Maximum at Beginning of FY13				Granted during FY13				Becoming Vested during FY13				Forfeited during FY13				Outstanding unvested grants at maximum at end of FY13
Restricted stock grants - employees		$	8.00			$	—			$	8.00			$	8.00			$	8.00
Restricted stock grants - directors			8.00				—				8.00				8.00				8.00
Matching award program			8.14				—				—				—				8.14
Bonus in stock - employees			8.50				6.44				9.31				—				8.15
Retainer in stock - directors			8.49				10.45				—				—				8.82
Total restricted stock plan		$	8.07			$	7.46			$	8.03			$	8.00			$	8.27

Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate.

+ References+ Details